Literature DB >> 32470238

Taste and smell as chemosensory dysfunctions in COVID-19 infection.

Pier Carmine Passarelli1, Michele Antonio Lopez2, Giuseppe Niccolò Mastandrea Bonaviri3, Franklin Garcia-Godoy4,5, Antonio D'Addona6.   

Abstract

PURPOSE: To review the literature on the presence of two clinical manifestations in patients presenting COVID-19 (SARS-CoV-2) infection: loss of taste (ageusia) and loss of smell (anosmia).
METHODS: PubMed and EMBASE were searched and studies were selected starting from November, 2019 until April 2020; also, the references of the selected articles were evaluated for methodological quality.
RESULTS: Of the 19 studies analyzed, five were included to evaluate the presence of ageusia and/or anosmia as symptoms in patients who were tested and resulted positive for the SARS-CoV-2 virus. In a total of 10,818 patients, 8,823 presented ageusia (81.6%; range 5.6%-88%) and 8,088 presented anosmia (74.8%; range 5.1-85.6%). Only one study recorded both symptoms with a percentage of 18.6%. CLINICAL SIGNIFICANCE: This systematic review demonstrated significant presence of ageusia and anosmia in the patients with COVID-19 infection. These symptoms may be considered as the first manifestation of the infection. Copyright©American Journal of Dentistry.

Entities:  

Mesh：

Year:  2020        PMID： 32470238

Source DB:  PubMed          Journal:  Am J Dent        ISSN： 0894-8275            Impact factor:   1.522


  22 in total

Review 1.  The impact of the COVID-19 infection in dentistry.

Authors:  Pier Carmine Passarelli; Edoardo Rella; Paolo Francesco Manicone; Franklin Garcia-Godoy; Antonio D'Addona
Journal:  Exp Biol Med (Maywood)       Date:  2020-05-21

2.  Oral manifestations in young adults infected with COVID-19 and impact of smoking: a multi-country cross-sectional study.

Authors:  Maha El Tantawi; Heba Jafar Sabbagh; Nada Abubakor Alkhateeb; Maryam Quritum; Joud Abourdan; Nafeesa Qureshi; Shabnum Qureshi; Ahmed Hamoud; Nada Mahmoud; Ruba Odeh; Nuraldeen Maher Al-Khanati; Rawiah Jaber; Abdulrahman Loaie Balkhoyor; Mohammed Shabi; Morenike O Folayan; Noha Gomaa; Raqiya Al Nahdi; Nawal Mahmoud; Hanane El Wazziki; Manal Alnaas; Bahia Samodien; Rawa Mahmoud; Nour Abu Assab; Sherin Saad; Sondos Al-Hachim; Ali Alshaikh; Wafaa Abdelaziz
Journal:  PeerJ       Date:  2022-07-15       Impact factor: 3.061

3.  Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences.

Authors:  Christopher S von Bartheld; Molly M Hagen; Rafal Butowt
Journal:  ACS Chem Neurosci       Date:  2020-09-17       Impact factor: 4.418

Review 4.  COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease.

Authors:  Che Mohd Nasril Che Mohd Nassir; Sabarisah Hashim; Kah Keng Wong; Sanihah Abdul Halim; Nur Suhaila Idris; Nanthini Jayabalan; Dazhi Guo; Muzaimi Mustapha
Journal:  Mol Neurobiol       Date:  2021-06-26       Impact factor: 5.590

5.  Oral manifestations of COVID-19 patients: An online survey of the Egyptian population.

Authors:  Dina M El Kady; Esraa Ahmad Gomaa; Walid Shaban Abdella; Reham Ashraf Hussien; Rawda H Abd ElAziz; Ahmad G A Khater
Journal:  Clin Exp Dent Res       Date:  2021-05-01

6.  Oral symptoms and lesions in SARS-CoV-2-positive patient.

Authors:  Ana Glavina; Dolores Biočina-Lukenda; Marinka Mravak-Stipetić; Jasenka Markeljević
Journal:  Oral Dis       Date:  2020-09-15       Impact factor: 4.068

7.  High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.

Authors:  Ana M B Menezes; Cesar G Victora; Fernando P Hartwig; Mariângela F Silveira; Bernardo L Horta; Aluísio J D Barros; Marilia A Mesenburg; Fernando C Wehrmeister; Lúcia C Pellanda; Odir A Dellagostin; Cláudio J Struchiner; Marcelo N Burattini; Fernando C Barros; Pedro C Hallal
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

Review 8.  Stopping the COVID-19 pandemic in dental offices: A review of SARS-CoV-2 transmission and cross-infection prevention.

Authors:  Maya Hartig; Carley Stephens; Aaron Foster; Douglas Fontes; Michael Kinzel; Franklin García-Godoy
Journal:  Exp Biol Med (Maywood)       Date:  2021-08-03

Review 9.  Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection.

Authors:  Jasvinder Singh Bhatti; Gurjit Kaur Bhatti; Naina Khullar; Arubala P Reddy; P Hemachandra Reddy
Journal:  Mol Neurobiol       Date:  2020-08-18       Impact factor: 5.590

Review 10.  Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection.

Authors:  Rafal Butowt; Christopher S von Bartheld
Journal:  Neuroscientist       Date:  2020-09-11       Impact factor: 7.519
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.